The main receptors of CCL-3 are CCR1 and CCR5, they are expressed on BMSCs, osteoclasts, osteoblasts, and MM cells, and they may have differential effects on osteolytic bone disease and MM cell migration. This evidence concerns the gene CCR5 and Miyoshi myopathy.